Literature DB >> 22076500

Intermittent hypobaric hypoxia preconditioning induced brain ischemic tolerance by up-regulating glial glutamate transporter-1 in rats.

Shu-Juan Gong1, Ling-Yu Chen, Min Zhang, Jian-Xue Gong, Ya-Xian Ma, Jian-Mei Zhang, Yu-Jing Wang, Yu-Yan Hu, Xiao-Cai Sun, Wen-Bin Li, Yi Zhang.   

Abstract

Several studies showed that the up-regulation of glial glutamate transporter-1 (GLT-1) participates in the acquisition of brain ischemic tolerance induced by cerebral ischemic preconditioning or ceftriaxone pretreatment in rats. To explore whether GLT-1 plays a role in the acquisition of brain ischemic tolerance induced by intermittent hypobaric hypoxia (IH) preconditioning (mimicking 5,000 m high-altitude, 6 h per day, once daily for 28 days), immunohistochemistry and western blot were used to observe the changes in the expression of GLT-1 protein in hippocampal CA1 subfield during the induction of brain ischemic tolerance by IH preconditioning, and the effect of dihydrokainate (DHK), an inhibitor of GLT-1, on the acquisition of brain ischemic tolerance in rats. The basal expression of GLT-1 protein in hippocampal CA1 subfield was significantly up-regulated by IH preconditioning, and at the same time astrocytes were activated by IH preconditioning, which appeared normal soma and aplenty slender processes. The GLT-1 expression was decreased at 7 days after 8-min global brain ischemia. When the rats were pretreated with the IH preconditioning before the global brain ischemia, the down-regulation of GLT-1 protein was prevented clearly. Neuropathological evaluation by thionin staining showed that 200 nmol DHK blocked the protective role of IH preconditioning against delayed neuronal death induced normally by 8-min global brain ischemia. Taken together, the up-regulation of GLT-1 protein participates in the acquisition of brain ischemic tolerance induced by IH preconditioning in rats.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076500     DOI: 10.1007/s11064-011-0639-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  35 in total

1.  The preconditioning modified neuronal expression of apoptosis-related proteins of Bcl-2 superfamily following severe hypobaric hypoxia in rats.

Authors:  Elena Rybnikova; Nadezhda Sitnik; Tatjana Gluschenko; Ekaterina Tjulkova; Michail O Samoilov
Journal:  Brain Res       Date:  2006-04-25       Impact factor: 3.252

2.  A new model of bilateral hemispheric ischemia in the unanesthetized rat.

Authors:  W A Pulsinelli; J B Brierley
Journal:  Stroke       Date:  1979 May-Jun       Impact factor: 7.914

3.  Intermittent hypoxia promotes hippocampal neurogenesis and produces antidepressant-like effects in adult rats.

Authors:  Xin-Hong Zhu; Hua-Cheng Yan; Jie Zhang; Hong-Da Qu; Xing-Sheng Qiu; Liang Chen; Shu-Ji Li; Xiong Cao; Jonathan C Bean; Long-Hua Chen; Xi-He Qin; Ji-Hong Liu; Xiao-Chun Bai; Lin Mei; Tian-Ming Gao
Journal:  J Neurosci       Date:  2010-09-22       Impact factor: 6.167

4.  Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

Authors:  J D Rothstein; M Dykes-Hoberg; C A Pardo; L A Bristol; L Jin; R W Kuncl; Y Kanai; M A Hediger; Y Wang; J P Schielke; D F Welty
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

Review 5.  Ischemic tolerance.

Authors:  Takaaki Kirino
Journal:  J Cereb Blood Flow Metab       Date:  2002-11       Impact factor: 6.200

6.  Antisense knockdown of the glial glutamate transporter GLT-1 exacerbates hippocampal neuronal damage following traumatic injury to rat brain.

Authors:  V L Rao; A Dogan; K K Bowen; K G Todd; R J Dempsey
Journal:  Eur J Neurosci       Date:  2001-01       Impact factor: 3.386

7.  Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia.

Authors:  Wei Liu; Meng Guo; Ya-Bei Xu; Dao Li; Zhao-Nian Zhou; Ying-Li Wu; Zhu Chen; Scott C Kogan; Guo-Qiang Chen
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

8.  Nitric oxide participates in the induction of brain ischemic tolerance via activating ERK1/2 signaling pathways.

Authors:  Hui-Qing Liu; Wen-Bin Li; Qing-Jun Li; Min Zhang; Xiao-Cai Sun; Rong-Fang Feng; Xiao-Hui Xian; Shu-Qin Li; Jie Qi; Hong-Gang Zhao
Journal:  Neurochem Res       Date:  2006-07-18       Impact factor: 3.996

9.  Effects of different modes of intermittent hypobaric hypoxia on ischemia/reperfusion injury in developing rat hearts.

Authors:  Hao Zhang; Chang-Ying Yang; Ying-Ping Wang; Xin Wang; Fang Cui; Zhao-Nian Zhou; Yi Zhang
Journal:  Sheng Li Xue Bao       Date:  2007-10-25

10.  Intermittent hypoxia exposure in a hypobaric chamber and erythropoietin abuse interpretation.

Authors:  Rosario Abellan; Rosa Ventura; Angel F Remacha; Ferran A Rodríguez; José A Pascual; Jordi Segura
Journal:  J Sports Sci       Date:  2007-09       Impact factor: 3.337

View more
  21 in total

1.  Bone morphogenic protein-7 contributes to cerebral ischemic preconditioning induced-ischemic tolerance by activating p38 mitogen-activated protein kinase signaling pathway.

Authors:  Junhong Guan; Han Li; Tao Lv; Duo Chen; Ye Yuan; Shengtao Qu
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

Review 2.  Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke.

Authors:  Yuechun Wang; Cesar Reis; Richard Applegate; Gary Stier; Robert Martin; John H Zhang
Journal:  Exp Neurol       Date:  2015-04-18       Impact factor: 5.330

Review 3.  Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrier.

Authors:  Diane C Lim; Allan I Pack
Journal:  Sleep Med Rev       Date:  2013-03-28       Impact factor: 11.609

4.  Intermittent hypoxia preconditioning-induced epileptic tolerance by upregulation of monocarboxylate transporter 4 expression in rat hippocampal astrocytes.

Authors:  Chen Gao; Chao Wang; Bei Liu; Hao Wu; Qianli Yang; Jungong Jin; Huanfa Li; Shan Dong; Guodong Gao; Hua Zhang
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

5.  Dichotomous effects of chronic intermittent hypoxia on focal cerebral ischemic injury.

Authors:  Katherine A Jackman; Ping Zhou; Giuseppe Faraco; Pablo M Peixoto; Christal Coleman; Henning U Voss; Virginia Pickel; Giovanni Manfredi; Costantino Iadecola
Journal:  Stroke       Date:  2014-04-08       Impact factor: 7.914

6.  Upregulation of glutamate metabolism by BYHWD in cultured astrocytes following oxygen-glucose deprivation/reoxygenation in part depends on the activation of p38 MAPK.

Authors:  Peng Yu; Li Guan; Lequan Zhou; Jianchao Guo; Ruixian Guo; Ruishan Lin; Wenting Ding; Xiaoying Li; Wei Liu
Journal:  Exp Ther Med       Date:  2017-04-12       Impact factor: 2.447

Review 7.  Cerebral Ischemic Preconditioning: the Road So Far….

Authors:  N Thushara Vijayakumar; Amit Sangwan; Bhargy Sharma; Arshad Majid; G K Rajanikant
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

8.  Chronic Intermittent Hypobaric Hypoxia Pretreatment Ameliorates Ischemia-Induced Cognitive Dysfunction Through Activation of ERK1/2-CREB-BDNF Pathway in Anesthetized Mice.

Authors:  Jintian Wang; Shixiao Zhang; Huijuan Ma; Shijie Yang; Zhao Liu; Xiaolei Wu; Sheng Wang; Yi Zhang; Yixian Liu
Journal:  Neurochem Res       Date:  2016-11-08       Impact factor: 3.996

9.  Buyang Huanwu decoction increases the expression of glutamate transporter-1 and glutamate synthetase in association with PACAP-38 following focal ischemia.

Authors:  Wenting Ding; Peng Yu; Wei Liu; Lequan Zhou; L I Guan; Ruishan Lin
Journal:  Biomed Rep       Date:  2015-06-15

10.  Nitric Oxide Participates in the Brain Ischemic Tolerance Induced by Intermittent Hypobaric Hypoxia in the Hippocampal CA1 Subfield in Rats.

Authors:  Ya-Jie Huang; Yu-Jia Yuan; Yi-Xian Liu; Meng-Yue Zhang; Jing-Ge Zhang; Tian-Ci Wang; Li-Nan Zhang; Yu-Yan Hu; Li Li; Xiao-Hui Xian; Jie Qi; Min Zhang
Journal:  Neurochem Res       Date:  2018-07-11       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.